Skip to main content
Eisai Co., Ltd. logo

Eisai Co., Ltd. — Investor Relations & Filings

Ticker · 4523 ISIN · JP3160400002 LEI · 353800HDEE0ZYEX4QV91 T Manufacturing
Filings indexed 79 across all filing types
Latest filing 2026-06-04 Capital/Financing Update
Country JP Japan
Listing T 4523

About Eisai Co., Ltd.

https://www.eisai.com/index.html

Eisai Co., Ltd. is a research-based global pharmaceutical company engaged in the discovery, development, manufacture, and marketing of prescription medicines. The company's primary business activities are concentrated in the therapeutic areas of neurology, with a significant focus on dementia-related diseases, and oncology. Guided by its core "human health care" (hhc) philosophy, Eisai prioritizes the needs of patients and their families. The company is dedicated to developing innovative and targeted treatments for challenging medical conditions and actively promotes initiatives to improve access to medicines in developing and emerging countries.

Recent filings

Filing Released Lang Actions
無担保社債の発行について
Capital/Financing Update Classification · 92% confidence The document is a corporate announcement by Eisai Co., Ltd. detailing the terms and conditions for the issuance of its 8th, 9th, and 10th unsecured bonds (amounts, maturities, coupon rates, etc.). This is a financing activity (debt issuance) aimed at raising capital. Therefore, it falls under Capital/Financing Update (CAP).
2026-06-04 Japanese
Notification Regarding Issuance of Unsecured Straight Bonds
Capital/Financing Update Classification · 90% confidence The document is a press release announcing the issuance of three series of unsecured straight bonds by Eisai Co., Ltd., detailing amounts, maturities, interest rates, and use of proceeds. This is a financing activity update, fitting the “Capital/Financing Update” category.
2026-06-04 English
発行登録追補書類(株券、社債券等)
Capital/Financing Update Classification · 92% confidence The document is a detailed issuance registration supplementary document (prospectus) for corporate bonds, outlining bond terms, amounts, interest, redemption, underwriters, and other legal provisions. This is not a general financial report or a simple publication notice but a full financing / fundraising document. Under our taxonomy, bond issuance falls under Capital/Financing Update (CAP), which covers company fundraising and financing activities.
2026-06-04 Japanese
「経営戦略説明会」資料
Investor Presentation Classification · 95% confidence The document is a detailed slide-style management strategy presentation (“経営戦略説明会”) by Eisai, covering three-year plans, R&D pipeline, financial targets, and business strategy. It includes an agenda, named presenters (COO, CSO, CFO), and extensive strategic and financial slides, characteristic of an investor presentation rather than a formal regulatory filing or earnings release. Hence it matches the Investor Presentation category.
2026-05-25 Japanese
訂正発行登録書
Capital/Financing Update Classification · 82% confidence The document is a corrected issuance registration statement (“訂正発行登録書”) submitted to the Kanto Finance Bureau concerning the registration of a bond issuance (corporate debt). This relates directly to the company’s financing activity (bond issuance), fitting the Capital/Financing Update category rather than a share issuance or other report type.
2026-05-15 Japanese
臨時報告書
Transaction in Own Shares Classification · 75% confidence The document is a Japanese 臨時報告書 (Timely Report) under the Financial Instruments and Exchange Act announcing the Board’s resolution to continue its Board Incentive Plan trust by disposing treasury shares to the trust. The core content is the self‐share disposal (345,600 shares) and detailed terms of that transaction. This most closely matches the “Transaction in Own Shares” category (POS).
2026-05-15 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.